Abstract:We read with great interest the article published recently in Brain by <a class="reflinks" href="#awaa391-B11">Oji et al. (2020b</a>) 'Variants in saposin D domain of prosaposin gene linked to Parkinson's disease', which reported variants in the saposin D domain of the prosaposin (PSAP) gene and their association with Parkinson's disease. PSAP encodes a prosaposin protein that degrades into four active saposins (A–D) (<a class="reflinks" href="#awaa391-B12">Ouled Amar Bencheikh et al., 2018</a>). Deficiency of saposin B is a known cause of metachromatic leukodystrophy (MLD); deficiency of saposin C is a known cause of Gaucher disease; whereas deficiency of saposin A may be a cause of atypical Krabbe disease (<a class="reflinks" href="#awaa391-B6">Kolnikova et al., 2019</a>). As an autosomal recessive causative gene of lysosomal storage disorders, heterozygous variants of the PSAP gene were found in three Japanese autosomal dominant Parkinson's disease families and the functional relevance of these variants located in saposin D domain and dopaminergic dysfunction was further confirmed by induced pluripotent stem cell and mouse model, as reported. Two intronic variants in saposin D domain were also found to be significantly associated with Parkinson's disease in the Japanese population. These results suggested a potential link between PSAP mutations and α-synuclein pathology. There is accumulating evidence for the genetic connection between lysosomal storage disorders and Parkinson's disease (<a class="reflinks" href="#awaa391-B3">Futerman and Hardy, 2016</a>; <a class="reflinks" href="#awaa391-B16">Robak et al., 2017</a>; <a class="reflinks" href="#awaa391-B5">Klein and Mazzulli, 2018</a>). It is also very interesting that the rare heterozygous variants of several lysosomal storage disorder-related genes that follow recessive inheritance were confirmed to be associated with Parkinson's disease, such as GBA (<a class="reflinks" href="#awaa391-B18">Sun et al., 2010</a>; <a class="reflinks" href="#awaa391-B4">Guo et al., 2015</a>), SMPD1 (<a class="reflinks" href="#awaa391-B8">Li et al., 2015</a>) and ARSA (<a class="reflinks" href="#awaa391-B7">Lee et al., 2019</a>). These interesting findings prompted us to explore the genetic role of PSAP variants in Parkinson's disease based on our data.

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents

Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease

Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome

Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson’s Disease

Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin

Prosaposin variants in sporadic, familial, and early-onset Parkinson's disease: a Taiwanese case–control study and meta-analysis

PSAP variants in Parkinson’s disease: a large cohort study in Chinese mainland population

The roles of prosaposin in neurological disorders: current understandings and prospects

Saposin C: neuronal effect and CNS delivery by liposomes

Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology

Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson's disease

Prosaposin is cleaved into saposins by multiple cathepsins in a progranulin-regulated fashion

Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism

Decrease in Prosaposin in the Dystrophic mdx Mouse Brain

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease

The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease

Amplification and overexpression of prosaposin in prostate cancer

Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease